Filing Details

Accession Number:
0000711377-13-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-13 18:29:40
Reporting Period:
2013-11-11
Filing Date:
2013-11-13
Accepted Time:
2013-11-13 18:29:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-11 47,720 $13.04 928,533 No 4 M Direct
Common Stock Disposition 2013-11-11 488 $47.68 928,045 No 4 S Direct
Common Stock Disposition 2013-11-12 9,512 $46.86 918,533 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2013-11-11 47,720 $0.00 47,720 $13.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
387,750 2014-08-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 378,480 Indirect See Footnote
Footnotes
  1. Options were granted 8/24/2009, have five year lives, and vest in equal annual installments on the anniversary date of the grant
  2. 180,000 shares are held in a limited liability corporation, of which Mr. Herbert is the sole owner,, and 198,480 are held in trust for Mr. Herbert's spouse